February 9, 2018 / 2:14 PM / 8 months ago

BRIEF-Teva Announces Launch Of A Generic Version Of Syprine In The U.S

Feb 9 (Reuters) - Teva Pharmaceutical Industries Ltd :

* TEVA ANNOUNCES LAUNCH OF A GENERIC VERSION OF SYPRINE® IN THE UNITED STATES

* TEVA PHARMACEUTICAL INDUSTRIES LTD - ‍LAUNCH OF GENERIC VERSION OF SYPRINE (TRIENTINE HYDROCHLORIDE) CAPSULES, 250 MG, IN U.S.​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below